BioMed Research International / 2019 / Article / Tab 2

Clinical Study

Early Recovery of Exercise-Related Muscular Injury by HBOT

Table 2

Comparative outcomes in serum enzymatic changes.

VariableHBOT (n=20)Control (n=21)P-value1
Mean ± SDMean ± SD

CPK(U/L)
T1245.4 ± 109.8342.1 ± 496.80.404
(166–1167)(82–289)
T3158.5 ± 78.0327.1 ± 181.10.001
(62–275)(152–796)
 P-value20.0050.908

GOT(U/L)
T121.8 ± 3.924.9 ± 8.80.402
(18–45)(11–30)
T318.2 ± 5.027.1 ± 12.60.004
(13–32)(12–38)
 P-value2<0.0010.483

Myoglobin (ng/mL)
T133.9 ± 15.435.6 ± 24.30.584
(20.5–94.5)(12.6–39.1)
T319.4 ± 10.243.3 ± 19.4<0.001
(13–17.5)(14.9–84.7)
 P-value20.0010.280

BUN (mg/dL)
T115.2 ± 2.714.2 ± 3.10.188
(10–20)(10–16)
T314.6 ± 3.314.5 ± 2.90.858
(9–15)(10–17)
 P-value20.3710.640

Lactate (mg/dL)
T111.0 ± 3.911.1 ± 4.30.958
(5.1–20.8)(5.4–19)
T311.2 ± 4.012.5 ± 3.70.163
(6.5–18.6)(8.3–36)
 P-value20.8930.123

Mann-Whitney U test was used to compare 2 groups
Generalized Estimating Equation (GEE) model was used to compare T1-T3
P-value1: Comparison of data between HBOT group and Control group
P-value2: Comparison of data between T1 and T3.
Note: The laboratory normal value of these blood markers: BUN: 6–21 mg/dl; CPK: 56–226 U/L; LT: 4.5–19.8 mg/dl; GOT: 0–37 U/L; MB: 17.4–105.7 ng/ml.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.